awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36484970-F923A824-4CAA-48F2-BAFF-8D1DDB36D233
Q36484970-F923A824-4CAA-48F2-BAFF-8D1DDB36D233
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36484970-F923A824-4CAA-48F2-BAFF-8D1DDB36D233
Docetaxel-associated epiphora.
P2860
Q36484970-F923A824-4CAA-48F2-BAFF-8D1DDB36D233
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36484970-F923A824-4CAA-48F2-BAFF-8D1DDB36D233
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4a2e7fdf90acc7432ca36e39396f5099724b2f7d
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).